Pacheco, BR
Anderson Ricardo Pacheco, Joinville BR
Patent application number | Description | Published |
---|---|---|
20100148016 | MOUNTING ARRANGEMENT FOR THE ENERGIZING CABLES OF AN ELECTRIC MOTOR OF A REFRIGERATION COMPRESSOR - The invention refers to a mounting arrangement for the energizing cables of an electric motor of a refrigeration compressor, the electric motor being mounted in the interior of a casing of the compressor and the energizing cables presenting an end connected to the electric motor and an opposite end operatively connected to an electric current power source, external to the casing, through the latter. The arrangement includes at least one immobilizing means mounted internally to the casing, so as to retain the energizing cables, maintaining at least part of the extension thereof in a predetermined positioning in the interior of the casing. | 06-17-2010 |
20110114243 | PROCESS AND ARRANGEMENT FOR ELECTRICALLY INSULATIANG A COIL OF AN ELECTRIC DEVICE - The invention is applied to an electric device comprising a reel ( | 05-19-2011 |
Antonio Ricardo Pacheco, Londrina BR
Patent application number | Description | Published |
---|---|---|
20100115809 | ADVERTISEMENT HANDLE COUPLED WITH GRAB BAR OF PASSENGER TRANSPORTATION VEHICLES - The invention relates to an ADVERTISEMENT HANDLE COUPLED WITH GRAB BAR OF PASSENGER TRANSPORTATION VEHICLES, comprising a construction solution in which there is a panel ( | 05-13-2010 |
Cristiane Rodrigues Da Silva Pacheco, Sao Paulo BR
Patent application number | Description | Published |
---|---|---|
20160045426 | STRUCTURING OF COSMETIC COMPOSTION USING ORGANOGELS - The present invention relates to process for preparing cosmetic compositions at two stages. The first relates to the preparation of organogels in which liquid oils are structured by a mixture of structuring agents such as monoglycerides and waxes, which also have the addition of other components such as polymers and polyol esters. The second step is the formation of the cold or hot process cosmetic compositions where emulsions are prepared by the addition of water, aqueous solutions and other components, to the organogel. The emulsions prepared have superior sensory, chemical-physical and stability characteristics, to those currently produced by the classic technology of preparation with emulsifiers. | 02-18-2016 |
Marcelo Edral Pacheco, Rio De Janeiro BR
Patent application number | Description | Published |
---|---|---|
20100270207 | PROCESS FOR HYDROTREATING BIOMASS OIL DILUTED IN A REFINERY STREAM OF PETROLEUM HYDROCARBONS - A co-processing combining a first selective catalytic bed consisting of only one metal element selected from group VIB metals and of at least one conventional hydrotreating bimetallic catalytic bed. The co-processing provides control of the hydroconversion reactions of the triglycerides and/or fatty acids of biomass oil diluted in a refinery stream of petroleum hydrocarbons and minimizes the generation of gaseous products that are undesirable to the process, while maintaining the levels of unsaturated hydrocarbons hydrogenation and of heteroatomic contaminants removal from the refinery stream of petroleum hydrocarbons. The co-processing selectively providing n-paraffins of even number of carbon atoms, generated from the biomass oil, which are incorporated in a hydrotreated liquid product in petroleum refining HDT units. | 10-28-2010 |
Ogari Pacheco, Nova Itapira BR
Patent application number | Description | Published |
---|---|---|
20090311292 | PROCESS FOR SYNTHESIS AND INCORPORATION OF NITRIC OXIDE DONORS IN MACROMOLECULAR COMPOSITIONS - The present invention describes a process for the synthesis of S-nitrosothiols and the subsequent incorporation of these compounds in hydrophilic macromolecular compositions. By the process described herein, the S-nitrosothiols are synthesized in a device (FIG. | 12-17-2009 |
Ogari Pacheco, Itapira Sp BR
Patent application number | Description | Published |
---|---|---|
20080286371 | Immunogenical Complex Formed by Vaccinal Antigens Encapsulated by Nanostructured Mesoporous Silica - The present invention relates to a product named “immunogenical complex”, which comprises an adjuvant characterized by solid particles of highly ordinated nanostructured mesoporous silica, preferably, SBA-15 Silica, and vaccinal antigens of several natures, encapsulated in the referred to adjuvants. The immunogenical complex of the present invention allows the presentation of the antigens that compose it to lymphocytes, in a safe, gradual and extended way, which leads to a more efficient immunological memory, increases the immunogenicity of the antigen and improves the production of antibodies. This ensures an efficient immunological protection with fewer amounts of antigens and/or less repetitions of vaccinal doses. In addition, the characteristics of the immunogenical complex of the present invention promotes effective immunity induction, homogeneous in “god and bad respondent” individuals. | 11-20-2008 |
Ogari Pacheco, Itapira BR
Patent application number | Description | Published |
---|---|---|
20090247791 | PROCESS FOR THE PREPARATION OF FLUOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL) ETHYL ETHER - The present invention refers to a process for the preparation of fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether (sevoflurane) which includes a step that consists of reacting hexafluoroisopropanol with a formaldehyde equivalent selected among paraformaldehyde or 1,3,5-trioxane, a chlorinating agent selected from the group consisting of oxalyl chloride, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, sulfuryl chloride and thionyl chloride, and a strong acid selected from the group consisting of concentrated or fuming sulfuric acid resulting in the formation of the intermediate sevochlorane which is converted to sevoflurane in a second step which consists of reacting sevochlorane with an alkali metal fluoride, or a linear or branched chain tetra-alkyl quarternary ammonium fluoride in the presence of a sub-stoichiometric quantity of an alkali metal iodide, or a linear or branched alkyl chain tetra-alkyl quarternary ammonium iodide, preferably in a solvent. | 10-01-2009 |
20100004490 | PROCESS FOR THE PREPARATION OF CHLOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL) ETHYL ETHER - The present invention refers to a process for the preparation of chloromethyl 2,2,2-trifluoro-1-(trifluoromethyl) ethyl ether (sevochlorane), which consists of reacting hexafluoroisopropanol with: a formaldehyde equivalent selected between paraformaldehyde or 1,3,5-trioxane, a chlorinating agent selected from the group consisting of oxalyl chloride, phosphorus trichloride, phosphorus pentachloride, phosphorus oxychloride, sulfuryl chloride and thionyl chloride, and a strong acid selected from the group consisting of concentrated or fuming sulfuric acid. Said process provides sevochlorane in high purity and yield, which can be converted to sevoflurane by known means. | 01-07-2010 |
20100041769 | STABLE AND READY-TO-USE OIL-IN-WATER PROPOFOL MICROEMULSION - The present invention describes a new propofol-containing anesthetic pharmaceutical composition for parenteral administration, in the form of an oil-in-water microemulsion in which the oily phase is constituted by propofol in the form of particles with size comprised between 1 and 100 nm using a single surfactant selected from the group consisting of polyethylene glycol stearates with general formula C | 02-18-2010 |
20150266864 | HETEROAROMATIC COMPOUNDS, METHOD FOR PREPARING THE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, USES AND METHOD FOR TREATING ACUTE AND CHRONIC PAIN - The present invention refers to a compound of formula (I) | 09-24-2015 |
Ogari De Castro Pacheco, Itapira BR
Patent application number | Description | Published |
---|---|---|
20120077788 | USE OF TELOCINOBUFAGIN AS AN ANALGESIC IN THE TREATMENT OF ACUTE AND CHRONIC PAINS; PHARMACEUTICAL COMPOSITION CONTAINING TELOCINOBUFAGIN AND ITS USE - The present invention is directed to the use of telocinobufagin, or its pharmaceutically acceptable derivatives, in the manufacture of a medicament for the treatment or prevention of acute and chronic pains. The present invention also refers to a pharmaceutical composition comprising an effective amount of telocinobufagin; also provides a method to induce analgesia in response to acute and chronic pains that comprehends administering an effective amount of telocinobufagin to human beings or animals. According to the outcomes of in vivo assays, telocinobufagin is more potent than morphine, though without presenting the known side effects of opioids. In addition, in vivo and in vitro essays showed that TBC does not present cardiotoxicity. | 03-29-2012 |
20150147313 | ANIMAL PRODUCT-FREE CULTURE MEDIUM FOR BACTERIA OF THE GENUS CLOSTRIDIUM AND A PROCESS FOR PRODUCING SUPERNATANT COMPRISING ONE OR MORE COLLAGENOLYTIC AND GELATINOLYTIC PROTEASES - The present invention refers to a culture medium and a process for producing proteases with collagenolytic and gelatinolytic activity by bacteria of the genus | 05-28-2015 |